Tag Directory / ACQUISITIONS     showing 1–3 of 3   RSS

for: Wednesday, January 07, 2026



Amgen acquires Oxford-based Dark Blue in deal worth up to €718 million to advance leukemia programme

David Cendon Garcia / eu-startups - Dark Blue Therapeutics, a British discovery and development BioTech company innovating the next generation of precision oncology medicines, has been acquired by US-based global BioTech company Amgen, in a transaction valued at up to €718 million ($840 mil…

#startups #vc #biotech #health #business #uk #europe #pharmaceuticals #acquisitions #research

Biotech Amgen acquires UK-based Dark Blue Therapeutics in $840m deal

1 month / siliconrepublic / Laura Varley

Amgen Acquires UK’s Dark Blue Therapeutics For Up To €718M To Advance Precision Oncology

1 month / startuprise / Kailee Rainse

Amgen acquires Oxford-based Dark Blue in deal worth up to €718 million to advance leukemia programme

1 month / eu-startups / David Cendon Garcia

Dark Blue Therapeutics acquired by Amgen for up to £622m

1 month / uktech / Kirstie Pickering

Second big exit for OSE: Dark Blue’s $840M sale to Amgen

2 months / techfundingnews / Abhinaya Prabhu

Back to Top / Wednesday, January 7, 2026, 9:21 am / permalink 17591 / 5 stories in 1 month


Warner Bros. Discovery rejects Paramount’s bid again, calls it a ‘leveraged buyout’

Ram Iyer / techcrunch - The studio's board unanimously rejected Paramount Skydance's revised $108.4 billion bid, calling the proposal a "leveraged buyout" that would saddle the company with $87 billion in debt.


Board opts Netflix over risky Paramount bid

Warner Bros. Discovery rejects Paramount’s $108.4 billion takeover bid

1 month / dataconomy / Emre Çıtak

‘More risk’: Warner Bros rejects revised Paramount takeover offer

1 month / mumbrella / Nathan Jolly

Warner Bros Rejects Revised Paramount Bid, Sticks With Netflix

1 month / slashdot / BeauHD

Warner Bros. rejects Paramount’s revised $108B takeover bid, sticks with Netflix deal - The Express Tribune

1 month / com

Warner Discovery Rejects Paramount’s Amended Hostile Bid - The Wall Street Journal

1 month / wsj

Warner Bros. rejects revised Paramount bid, citing risky leveraged buyout - MS NOW

1 month / ms

Warner Bros rejects revised Paramount bid, continues with Netflix - WION

1 month / wionews

WBD Board Rejects Revised Paramount $108.4 Billion Bid, Sticks With Accepted Netflix Offer - Media Play News

1 month / mediaplaynews

WBD Rejects Revised Paramount $108.4 Billion Bid, Sticks With Accepted Netflix Offer

1 month / mediaplaynews / Erik Gruenwedel

Warner Bros. Discovery rejects Paramount’s bid again, calls it a ‘leveraged buyout’

1 month / techcrunch / Ram Iyer

Warners Bros. Discovery board urges shareholders to reject amended Paramount bid

1 month / engadget / Andre Revilla

Warner Bros., unswayed by Ellison backing of Paramount bid, sticks with Netflix

1 month / x / @MarketWatch

WBD rejects latest Paramount offer; backs Netflix deal

1 month / advanced-television / Nick Snow


Industry warns of broader deal risks

GOP focused on prices, not labour, with Netflix/WB

1 month / globalcompetitionreview / Anna Langlois

Exhibitor Trade Group Warns Against Netflix or Paramount Acquiring Warner Bros. Studios

1 month / mediaplaynews / Erik Gruenwedel


Larry Ellison’s backing falls short for Paramount

Warner Bros. sticks with Netflix merger, calls Paramount’s $108B bid “illusory”

1 month / arstechnica / Jon Brodkin

Warner Bros. tells shareholders that Larry Ellison’s wealth isn’t enough to best Netflix bid

1 month / x / @MarketWatch


Shareholder blasts board’s negotiation approach

WBD Shareholder Claims Board Not Negotiating With Paramount in Good Faith

1 month / mediaplaynews / Erik Gruenwedel

Back to Top / Wednesday, January 7, 2026, 9:20 am / permalink 17590 / 18 stories in 1 month


Beijing mulls intervention in Meta’s deal to buy Manus amid AI ‘brain drain’ fears

scmp - Chinese authorities are considering whether to step in over Meta Platforms’ acquisition of Manus – an artificial intellligence agent developer with Chinese roots – amid concerns the deal could breach technology export controls and encourage more start-ups…


China's Export Control Crackdown

Chinese regulators probe Meta’s acquisition of AI startup Manus

1 month / siliconangle / Mike Wheatley

China Reviews Meta’s $2 Billion Deal to Buy AI Startup Manus

2 months / bloomberg / Bloomberg News

China probes Meta’s Manus deal over export control concerns

2 months / dataconomy / Emre Çıtak

China investigates Meta's Manus acquisition for export control violations

2 months / the-decoder / Matthias Bastian

Chinese authorities reviewing Meta $2bn acquisition of Manus – FT

2 months / siliconrepublic / Ann O’Dea

China weighs Meta’s Manus deal in widening battle over AI and tech control - Moneycontrol

2 months / moneycontrol

Beijing mulls intervention in Meta’s deal to buy Manus amid AI ‘brain drain’ fears

2 months / scmp

China Reviews Meta’s $2 Billion AI Deal With Manus Amid Technology Control Concerns - EconoTimes

2 months / econotimes

China reviews Meta’s $2bn purchase of AI start-up Manus

2 months / ft


US–Beijing Divergent Reactions

Meta’s Manus news is getting different receptions in Washington and Beijing

2 months / techcrunch / Connie Loizos

Meta’s Manus news is getting different receptions in Washington and Beijing - Yahoo Finance

2 months / yahoo


Wider US–China Tech Tensions

China heightens scrutiny of US tech ties

1 month / semafor / J.D. Capelouto

Meta’s $2 Billion Manus Acquisition Faces Regulatory Challenges Amid US China AI Tensions - Букви

2 months / mezha

Meta Faces Dual Challenges: Regulatory Scrutiny and Supply Constraints - AD HOC NEWS

2 months / ad-hoc-news

Back to Top / Wednesday, January 7, 2026, 1:20 am / permalink 17580 / 14 stories in 2 months


Back to Top


ACQUISITIONS Heatmap

90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.



More Top Stories...

Pentagon labels Anthropic a supply‑chain risk; company vows legal fight

The Pentagon has designated Anthropic and its products as a “supply‑chain risk,” prompting the company to announce a court challenge. Experts warn the move could chill collaboration and talent flows into AI, while Anthropic insists it will contest the determination to protect its operations and customers. More...


Oracle and OpenAI scrap Texas data-center expansion; Meta eyes the spare capacity

Oracle and OpenAI have abandoned plans to expand a flagship Texas data center, leaving substantial compute capacity up for grabs. Nvidia reportedly brokered interest from Meta to take the unused slots as OpenAI downscales that particular buildout, a move that rattled markets and highlights shifting demand for large-scale on-prem AI infrastructure. More...


SoftBank seeks massive $40B loan to back OpenAI investment, courting big risk

SoftBank is reportedly seeking up to a $40 billion loan to finance its planned stake in OpenAI, an audacious use of leverage to double down on the AI boom. The move would be one of the largest single‑company financing gambits in recent memory, raising questions about balance‑sheet strain versus potential upside. More...


OpenAI launches Codex Security agent to automatically detect software vulnerabilities

OpenAI rolled out Codex Security, an AI agent that scans codebases to find complex vulnerabilities, suggests actionable fixes, and uses sandbox testing to limit false positives. The tool has already flagged issues in major projects and aims to compete with traditional application security tooling by automating deep, contextual code review. More...


Google releases Workspace CLI enabling AI agents to access Gmail, Drive, Calendar

Google has shipped an open-source Workspace CLI that gives AI agents like OpenClaw programmatic access to Gmail, Drive, Calendar and other Workspace services via a built-in MCP server. The tool standardizes agent integration, making it easier — and slightly creepier — for automated assistants to act on users’ behalf across core productivity apps. More...


NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.